focus -WSS

focus

author：entertainment 2025-09-27 14:20:08 - browse：3

U.S. legislation that would sever ties with Chinese drugmakers would jeopardize the drug supply for millions of American patients if it’s passed, the biotechnology industry’s main trade group has told Congress.

Congress is considering legislation, called the BIOSECURE Act, that would make it difficult for Chinese contract development and manufacturing organizations to do business with biotechnology companies that work with the U.S. federal government. Biotechs hire Chinese CDMOs, as they’re often called, for services that include product manufacturing, development, formulation, packaging, and distribution.

The BIOSECURE Act would stop the federal government from contracting with, or providing grants to, companies that do business with so-called Chinese “companies of concern.” The impact of the legislation would depend in large part on who is in the White House. The White House’s Office of Management and Budget would determine which companies are blacklisted, but a handful of specific companies would automatically go on that list, including the biotech giant WuXi AppTec.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： 4th of July breaks record for highest global temperature ever measured

focus

entertainment

WSS

7 people shot in DC, police say

Physician executives need more than on

What to expect at HLTH 2023, the health care industry conference

These geoengineering technologies could help combat the climate crisis, scientists say

Senate panel eyes new effort on drug shortages

VC firm General Catalyst wants to buy a health system

focus

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

knowledge

Walensky prepares to leave CDC — and Congress — behind

Grail is spending more than ever lobbying Congress

Jerome Adams on the need for new antivirals for Covid

What to expect at HLTH 2023, the health care industry conference

Medical records are filled with copy

Liquid biopsy for lung cancer is launched by Delfi

Bright Health sells Medicare Advantage business to Molina

Connecting traumatic brain injury and domestic violence

What does generative AI mean for health care? We asked experts

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

Wikipedia

3 questions for the future of Biden's cancer moonshot

Senate panel eyes new effort on drug shortages

Meta looks to target Twitter with a rival app called Threads

Can food be medicine? And other questions about a new push

AI can decode, harness the power of the humane immune system

Option Care buys Amedisys in $3.6 billion home care deal

focus

focus

entertainment

focus